Did you mean velneperit of s 2019 of ベルネペリット?
Displaying drugs 4551 - 4575 of 10637 in total
6-(2-phenoxyethoxy)-1,3,5-triazine-2,4-diamine
Experimental
Etryptamine
In the 1960's, alpha-ethyltryptamine (αET), a non hydrazine reversible monoamine oxidase inhibitor, was developed in the United States by the Upjohn chemical company for use as an antidepressant. αET was an FDA approved antidepressant under the name Monase. However, in 1962, after the discovery of an unacceptable incidence of agranulocytosis,...
Illicit
Investigational
Withdrawn
Matched Description: … Substances, after an increasing incidence of its use as a recreational drug in the 1980's. ... In the 1960's, alpha-ethyltryptamine (αET), a non hydrazine reversible monoamine oxidase inhibitor, was ... However, in 1962, after the discovery of an unacceptable incidence of agranulocytosis, the development …
GTX-102
GTX-102 is an antisense oligonucleotide designed to target and inhibit the expression of UBE3A-AS. It is being investigated for the treatment of Angelman Syndrome.
Investigational
Matched Description: … It is being investigated for the treatment of Angelman Syndrome.[L46772] ... GTX-102 is an antisense oligonucleotide designed to target and inhibit the expression of UBE3A-AS. …
Matched Categories: … Antisense Oligonucleotide Specific to the Antisense Transcript of UBE3A …
Matched Categories: … Antisense Oligonucleotide Specific to the Antisense Transcript of UBE3A …
Bebtelovimab
Bebtelovimab (LY-COV1404, LY-3853113) is a human monoclonal antibody approved for emergency use in the treatment of COVID-19. It binds to a portion of the SARS-CoV-2 spike (S) protein's receptor-binding domain, thereby preventing spike protein interaction with ACE2 and subsequent viral entry into host cells. Bebtelovimab is notable in that the...
Investigational
Withdrawn
Matched Description: … It binds to a portion of the SARS-CoV-2 spike (S) protein's receptor-binding domain, thereby preventing ... (LY-COV1404, LY-3853113) is a human monoclonal antibody approved for emergency use in the treatment of ... its expected reduced activity against certain emerging Omicron subvariants of SARS-CoV-2. …
Cibacron Blue
Experimental
2-(3-OXO-PROPYLSULFANYLCARBONYL)-ETHANETHIOLATE
Experimental
Tribenuron Methyl
Experimental
VGA039
VGA039 is an IgG4 monoclonal antibody directed against protein S.
Investigational
Matched Description: … VGA039 is an IgG4 monoclonal antibody directed against protein S. …
Exebacase
Exebacase is under investigation in clinical trial NCT03163446 (Safety, Efficacy and Pharmacokinetics of CF-301 vs. Placebo in Addition to Antibacterial Therapy for Treatment of S. Aureus Bacteremia).
Investigational
Matched Description: … Placebo in Addition to Antibacterial Therapy for Treatment of S. Aureus Bacteremia). ... Exebacase is under investigation in clinical trial NCT03163446 (Safety, Efficacy and Pharmacokinetics of …
Redasemtide
Redasemtide is under investigation in clinical trial NCT05953480 (A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke).
Investigational
Matched Description: … Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke). ... Redasemtide is under investigation in clinical trial NCT05953480 (A Phase 2b, Randomized, Double-blind Study of …
Levodropropizine
Levodropropizine is under investigation in clinical trial NCT01573663 (A Drug-Drug Interaction Study of Ambroxol and Levodropropizine).
Investigational
Matched Description: … Levodropropizine is under investigation in clinical trial NCT01573663 (A Drug-Drug Interaction Study of …
Matched Products: … DROPOLEV-S 30 MG/5 ML ŞURUP …
Matched Products: … DROPOLEV-S 30 MG/5 ML ŞURUP …
Nomacopan
Nomacopan is under investigation in clinical trial NCT03427060 (Coversin in PNH in Patients With Resistance to Eculizumab Due to Complement C5 Polymorphisms).
Investigational
Matched Categories: … Recombinant Protein Inhibitor of Complement Factor 5 …
REP8839
REP8839 is a novel methionyl-tRNA synthetase (MetS) inhibitor being developed by Replidyne (GlaxoSmithKline licensed REP8839 to Replidyne in June of 2003).
Investigational
Matched Description: … MetS) inhibitor being developed by Replidyne (GlaxoSmithKline licensed REP8839 to Replidyne in June of …
Atrazine
Atrazine is a selective triazine herbicide. Inhalation hazard is low and there are no apparent skin manifestations or other toxicity in humans. Acutely poisoned sheep and cattle may show muscular spasms, fasciculations, stiff gait, increased respiratory rates, adrenal degeneration, and congestion of the lungs, liver, and kidneys. (From The Merck...
Experimental
Matched Description: … spasms, fasciculations, stiff gait, increased respiratory rates, adrenal degeneration, and congestion of …
Hypochlorous acid
An oxyacid of chlorine (HClO) containing monovalent chlorine that acts as an oxidizing or reducing agent.
Experimental
Matched Description: … An oxyacid of chlorine (HClO) containing monovalent chlorine that acts as an oxidizing or reducing agent …
Matched Products: … AbsoClean-S Sanitizing Mist …
Matched Products: … AbsoClean-S Sanitizing Mist …
MW33
MW33 is a recombinant fully human antibody to SARS-CoV-2. This antibody injection is currently being investigated against COVID-19 in the clinical trial NCT04533048 (A Clinical Study to Evaluate MW33 Injection).
Investigational
Displaying drugs 4551 - 4575 of 10637 in total